ASCO Virtual Meeting, 29 May–2 June 2020

A Phase Ia/Ib, dose-escalation/expansion study of BI 907828 in combination with BI 754091 and BI 754111 in patients with advanced solid tumors

Anthony Tolcher, Navid Hafez, Noboru Yamamoto, Jaehong Park, Rolf Grempler, Anthony Lucarelli, Mehdi Lahmar, Bushi Wang, Mrinal Gounder

asco_2020_poster_390_tolcher_mdm2_1403.2_tip.png

Study design and objectives

Study design and objectives

Endpoints and assessments – Phase Ia

Endpoints and assessments – Phase Ia

Endpoints and assessments – Phase Ib

Endpoints and assessments – Phase Ib

References

References

Related Materials

Learn more about the science behind this poster in the videos, papers and other materials below.

FOR HEALTHCARE PROFESSIONAL ONLY

links_to_3rd_party.jpg